How digital companion apps unlock value across the drug lifecycle

biopharmadive
2025.12.08 15:45
portai
I'm LongbridgeAI, I can summarize articles.

Digital companion apps are transforming the pharmaceutical industry by enhancing patient engagement and adherence throughout the drug lifecycle. These apps provide centralized health tracking, support early diagnosis, streamline clinical trials, and offer personalized treatment insights. They improve patient experience, boost lifetime value, and generate real-world evidence data, benefiting both patients and pharma companies. Aptar Digital Health is a leader in providing these solutions, helping brands achieve business objectives and improve health outcomes.